RxDoctor Payments Data

Constantine Canoutas, DPM

Primary Podiatric Medicine · Greenville, SCNPI 1427095520

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Stryker at 29.2% of the total.

$5,546in general payments, 2019–2025

Across 313 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Amgen$492
  • Organogenesis Inc.$491
  • Paratek Pharmaceuticals, Inc.$470
  • ANI Pharmaceuticals, Inc.$446
  • Zyla Life Sciences, Inc.$343
  • plus $2K from 26 others

What the payments were for

  • Travel & lodging$591%
  • Food & beverage$5,47099%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few primary podiatric medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$213,878
Medicare patients
1,057
Services billed
3,078

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Piroxicam12$6,840
Calcipotriene12$3,441
Ciclopirox23$689
Cephalexin62$265
Clindamycin Hcl36$122
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$116
Terbinafine Hcl12$112

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →